The Effect of Depression on Adherence to HIV Pre-exposure Prophylaxis Among High-Risk South African Women in HPTN 067/ADAPT
- 30 June 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in AIDS and Behavior
- Vol. 24 (7), 2178-2187
- https://doi.org/10.1007/s10461-020-02783-8
Abstract
Oral pre-exposure prophylaxis (PrEP) is highly efficacious but low adherence undermines effectiveness. Depression, common in African women, may be a barrier to consistent PrEP use. We aimed to assess the relationship between depression, psychosocial mediators, and PrEP adherence among South African women. We analyzed data from 174 South African women in HPTN 067, an open-label oral PrEP trial conducted from 2011 to 2013. Participants were followed for 24 weeks. PrEP adherence was measured via Wisepill (TM) and weekly self-report interview data. We considered participants "adherent" at week 24 if Wisepill (TM) and interviews indicated that >= 80% of expected doses were taken in the prior month. Elevated depressive symptoms were assessed using the 20-item Center for Epidemiological Studies-Depression (CES-D) scale. We used marginal structural models to estimate the effect of elevated symptoms at baseline on PrEP adherence at week 24 and to assess whether the direct effect changed meaningfully after accounting for mediating effects of stigma, social support, and PrEP optimism. High PrEP adherence occurred less often among women with elevated depressive symptoms (N = 35; 44.3%) compared with those without (N = 52; 54.7%; adjusted relative risk [aRR]: 0.79; 95% confidence interval [CI] 0.63-0.99). The effect of elevated depressive symptoms on PrEP adherence persisted in models accounting for the mediating influence of stigma (aRR: 0.74; 95% CI 0.51-0.97) and PrEP optimism (aRR: 0.75; 95% CI 0.55-0.99). We also found a direct effect of similar magnitude and direction when accounting for social support as the mediating variable, although this adjusted relative risk estimate was not statistically significant (aRR: 0.77; 95% CI 0.57-1.03). Depressive symptoms were common and associated with lower PrEP adherence among South African women. Future work is needed to determine whether depression services integrated with PrEP delivery could improve PrEP effectiveness among African women.Funding Information
- National Institute of Allergy and Infectious Diseases (UM1-AI068619, UM1-AI068617, UM1-AI068613, R01 AI118575, UM1AI069418)
- National Institute of Mental Health (F31 MH113420)
This publication has 38 references indexed in Scilit:
- Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in BotswanaThe New England Journal of Medicine, 2012
- Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and WomenThe New England Journal of Medicine, 2012
- Depression, Alcohol Use and Adherence to Antiretroviral Therapy in Sub-Saharan Africa: A Systematic ReviewAIDS and Behavior, 2011
- Relation of depression to perceived social support: Results from a randomized adolescent depression prevention trialBehaviour Research and Therapy, 2011
- A Structural Equation Model of HIV-Related Stigma, Depressive Symptoms, and Medication AdherenceAIDS and Behavior, 2011
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with MenThe New England Journal of Medicine, 2010
- Toward an information–motivation–behavioral skills model of microbicide adherence in clinical trialsAIDS Care, 2010
- Behavioral Mediation of the Relationship Between Psychosocial Factors and HIV Disease ProgressionPsychosomatic Medicine, 2008
- Sexual functioning and self‐reported depressive symptoms among college womenThe Journal of Sex Research, 2002
- The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibilityAddiction, 2002